1. Home
  2. CISS vs ARTL Comparison

CISS vs ARTL Comparison

Compare CISS & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CISS
  • ARTL
  • Stock Information
  • Founded
  • CISS 2022
  • ARTL 2011
  • Country
  • CISS Greece
  • ARTL United States
  • Employees
  • CISS N/A
  • ARTL N/A
  • Industry
  • CISS Marine Transportation
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CISS Consumer Discretionary
  • ARTL Health Care
  • Exchange
  • CISS Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • CISS 2.8M
  • ARTL 3.1M
  • IPO Year
  • CISS N/A
  • ARTL N/A
  • Fundamental
  • Price
  • CISS $3.35
  • ARTL $23.88
  • Analyst Decision
  • CISS
  • ARTL Strong Buy
  • Analyst Count
  • CISS 0
  • ARTL 2
  • Target Price
  • CISS N/A
  • ARTL $25.00
  • AVG Volume (30 Days)
  • CISS 125.1K
  • ARTL 1.9M
  • Earning Date
  • CISS 08-21-2025
  • ARTL 08-12-2025
  • Dividend Yield
  • CISS N/A
  • ARTL N/A
  • EPS Growth
  • CISS N/A
  • ARTL N/A
  • EPS
  • CISS N/A
  • ARTL N/A
  • Revenue
  • CISS $38,174,754.00
  • ARTL N/A
  • Revenue This Year
  • CISS N/A
  • ARTL N/A
  • Revenue Next Year
  • CISS N/A
  • ARTL N/A
  • P/E Ratio
  • CISS N/A
  • ARTL N/A
  • Revenue Growth
  • CISS N/A
  • ARTL N/A
  • 52 Week Low
  • CISS $2.85
  • ARTL $4.92
  • 52 Week High
  • CISS $23.25
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • CISS 44.02
  • ARTL 72.07
  • Support Level
  • CISS $3.26
  • ARTL $9.11
  • Resistance Level
  • CISS $3.49
  • ARTL $28.60
  • Average True Range (ATR)
  • CISS 0.23
  • ARTL 4.19
  • MACD
  • CISS -0.00
  • ARTL 1.92
  • Stochastic Oscillator
  • CISS 28.72
  • ARTL 79.31

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: